
|Articles|November 1, 2004
- Volume 0 0
Children's Behavioral Medication Costs Soar
Advertisement
Medco Health Solutions 2004 DrugTrend Report has revealed eye-openingdata about medication spending totreat behavioral disorders in pediatricpatients. Specifically, spending ondrugs primarily used to treat attention-deficit/hyperactivity disorder skyrocketedby 369% for children under age 5.The number of children taking 1 ormore prescription medications to treatbehavior-related conditions hit almost9% for those children taking at least 1medication overall. Other significantfindings of the analysis are as follows:
- Prescription drug spending forbehavioral conditions rose by77% between 2000 and 2003 as aresult of increased costs and theincreased use of these medications
- In 2003, spending on behavioralmedications to treat childrenovertook both the antibiotic andasthma categories, which are traditionallyhigh-use categories inpediatric medicine
- The number of children takingbehavioral medications jumpedby >20% between 2000 and 2003,outpaced only by the increase inchildren on drugs to treat gastrointestinalconditions, whichincreased by 28%
Articles in this issue
almost 22 years ago
Geriatric Pharmacologyalmost 22 years ago
Management of Bacterial Rhinosinusitisalmost 22 years ago
Early RA Treatment Proves Beneficialalmost 22 years ago
Topical Creams Work Temporarilyalmost 22 years ago
Mental Anguish Is Common with Arthritisalmost 22 years ago
Overview of Astrocytomas?The Pharmacist's Perspectivealmost 22 years ago
Scanner Detects Hand Arthritisalmost 22 years ago
OA: All in the Familyalmost 22 years ago
Sheriff Sues Board for Searching His Rx Records Without a Warrantalmost 22 years ago
Restricting the Sale of Cold MedicationsAdvertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacy Is a Practice, Not Just a Place
2
Mosunetuzumab Plus Polatuzumab Shows Nearly 80% Complete Response Rate in Mantle Cell Lymphoma After BTK Inhibitors
3
Closing the Calcium Gap: How Pharmacists Can Guide Patients Toward Better Bone Health
4
Beyond mRNA: A Pharmacist’s Guide to the Full COVID-19 Vaccine Landscape
5




































































































